Baumer S.A.

São Paulo Stock Exchange BALM4.SA

Baumer S.A. Return on Equity (ROE) for the year ending December 31, 2023: 6.20%

Baumer S.A. Return on Equity (ROE) is 6.20% for the year ending December 31, 2023, a 44.98% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Baumer S.A. Return on Equity (ROE) for the year ending December 31, 2022 was 4.28%, a -45.05% change year over year.
Baumer S.A. Return on Equity (ROE) for the year ending December 31, 2021 was 7.78%, a -46.45% change year over year.
Baumer S.A. Return on Equity (ROE) for the year ending December 31, 2020 was 14.53%, a 248.27% change year over year.
Baumer S.A. Return on Equity (ROE) for the year ending December 31, 2019 was 4.17%, a 42.51% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

São Paulo Stock Exchange: BALM4.SA

Baumer S.A.

CEO	Mr. Ruy Salvari Baumer
IPO Date	Feb. 16, 2007
Location	Brazil
Headquarters	Avenida Arnolfo Azevedo, 210
Employees	6
Sector	Materials
Industries Plastics 3D Printing Biotechnology Chemicals & Advanced Materials Cleaning Supplies Dental Care Medical Instruments Robotics

Description

Baumer S.A. develops solutions in hospitals, odontology, and health industry equipment in Brazil, Europe, Asia, and the United States. It offers sterilization and infection control solutions, such as steam sterilizers, formoldehyde and hydrogen peroxide steam sterilizers, solid waste treatment systems, ethylene oxide sterilizers, thermal washer disinfectors, drying cabinets, ultrasonic reprocessors, preparation and storage systems, loading and water treatment systems, test and control, and steam generators. The company also provides surgical center solutions, including anesthesia systems, lighting products, and surgical tables; and orthopedic solutions consisting of hip and knee prosthesis, shoulder prosthesis, non-conventional orthopedic solutions, intramedullary fixation solutions, external and internal fixations, and biomaterials. In addition, it offers spine solutions, such as pedicle fixation system, occipitocervial fixation systems, cervical cage angled, and posterior lumbar cages. Further, the company offers dental solutions, including implants and biomaterials. It serves hospitals, clinics, hemocenters, universities, public health service, and carrier health markets; and pharmaceutical, food, and cosmetics industries, as well as research institutes and laboratories. The company was founded in 1952 and is based in Pacaembu, Brazil.

Key trends

Past 5 years